Search Results 2131-2140 of 16241 for Epilepsy (Partial Onset)

1. Immune Predictors of Response to Pembrolizumab Therapy in Stage IV Melanoma Patients - Mayo Clinic

   ... duration of the trial, or is not in the best interest of the subject to participate, in the opinion of the treating investigator. Has known psychiatric or ...

2. Extending Preservation and Assessment Time of Donor Lungs Using the Toronto EVLP System™ at a Dedicated EVLP Facility - Mayo Clinic

   About this study. This is a safety study to compare the safety of receiving a lung treated with the Toronto EVLP System™ by SPONSOR in SPONSOR's dedicated ...

3. A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma - Mayo Clinic

   There are also less common very early (phase 0) and later (phase 4) phases. ... duration of their study participation and for 12 weeks after stopping study ...

4. MyAirvo 3 (High Flow Nasal Therapy; HFNT) For COPD Patients In The Home - Mayo Clinic

   ... duration of the study. Male or female, aged 30 years or greater. FEV1/FVC of < 70% and an FEV1 of < 80% (GOLD stages II - IV, Grade E). • Spirometry performed ...

5. Analyses of Metabolic Agents Following Brain Radiation - Mayo Clinic

   Willing and able to adhere with the protocol for the duration of the study including undergoing treatment and scheduled visits, and examinations. The ...

6. ACP-196 in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies - Mayo Clinic

   The purpose of this study is to characterize the safety profile of acalabrutinib and pembrolizumab in subjects with hematologic malignancies. Participation ...

7. TIMELY-PLEX - Mayo Clinic

   A Randomized Controlled, Open-label, Rater-blinded Pragmatic trial, “Treatment of Inflammatory Myelitis and Optic Neuritis with Early ... Within 8 days of onset ...

8. A Study to Compare Venetoclax with Fulvestrant vs. Fulvestrant Alone in Women with Locally Advanced or Metastatic HER2-negative Cancer who Have Progressed or Recurred on a CDK4/6 Inhibitor - Mayo Clinic

   If patients have received an alternative LHRH agonist prior to study entry, they must switch to goserelin for the duration of the trial. ... duration of the ...

9. A Study to Evaluate the Safety, Tolerability and Metabolism of BIIB105 in Subjects with Amyotrophic Lateral Sclerosis - Mayo Clinic

   There are also less common very early (phase 0) and later (phase 4) phases. ... partial thromboplastin time (aPTT) should be ... onset to date of Screening). This

10. A Study to Evaluate the Effectiveness and Safety of Benralizumab in Patients with Hypereosinophilic Syndrome (HES) - Mayo Clinic

    ... duration, and within 12 weeks after last dose of IP and have a negative ... duration of the clinical study and the preferred and usual lifestyle of the patient)